Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthesizing method of vilanterol intermediate

A synthetic method and intermediate technology, applied in the field of drug synthesis, can solve the problems of reducing production costs and reducing the steps of vilanterol synthesis, and achieve the effects of reducing production costs, shortening synthetic routes, and simple operation

Active Publication Date: 2019-04-23
安徽德信佳济大新药技术有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] According to domestic and foreign literature reports, there is no synthetic route about 3-hydroxymethyl-4-hydroxymandelic acid at present, therefore, the synthesis of 3-hydroxymethyl-4-hydroxymandelic acid is very important, not only can reduce the Luo synthesis steps, but also greatly reduce production costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesizing method of vilanterol intermediate
  • Synthesizing method of vilanterol intermediate
  • Synthesizing method of vilanterol intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Add 4-hydroxymandelic acid (16.8g), paraformaldehyde (9g) into the there-necked flask, add glacial acetic acid (85mL), FeCl 3 (0.8g), reacted at 80°C for 4h, the reaction in TLC was completed, cooled to room temperature, concentrated the solvent in vacuo, added water (100mL) to the residue, stirred for half an hour, filtered to obtain a solid, and the crude product was recrystallized from ethanol to obtain 13.5 g of 4-hydroxy-3-formylmandelic acid, yield 68%, purity 98%.

[0019] Note: 4-Hydroxymandelic acid was purchased from Jiangxi Keyuan Biopharmaceutical Co., Ltd., and the purity of the raw material was 98%.

Embodiment 2

[0021] Add 4-hydroxymandelic acid (50.4g), paraformaldehyde (27g) in the there-necked flask, add trifluoroacetic acid (250mL), ZnCl 2 (2g), reacted at 70°C for 4h, the reaction in TLC was completed, cooled to room temperature, concentrated the solvent in vacuo, added water (200mL) to the residue, stirred for half an hour, filtered to obtain a solid, and the crude product was recrystallized from ethanol to obtain 4 -Hydroxy-3-formylmandelic acid 41g, yield 70%, purity 98%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthesizing method of a vilanterol intermediate and belongs to the field of drug synthesis. According to the synthesizing method of the vilanterol intermediate, 4-hydroxymandelic acid serving as the raw material is prepared through electrophilic substitution reaction into 3-hydroxymethyl-4-hydroxymandelic acid. The prepared new vilanterol intermediate is simple in raw material acquisition and operation, and when applied to synthesizing vilanterol, can greatly shortens the synthetic route and reduce the production cost, thereby being applicable to industrial production.

Description

technical field [0001] The invention belongs to the field of drug synthesis, and relates to a method for synthesizing the intermediate 3-hydroxymethyl-4-hydroxymandelic acid of the anti-asthma drug vilanterol. Background technique [0002] Vilanterol is a long-acting beta drug developed by GlaxoSmithKline (GSK) 2 receptor agonist. Its compound preparation with fluticasone furoate and its compound preparation with umeclidinium bromide were approved by FDA in May and December 2013, respectively, for the treatment of obstructive pulmonary disease and asthma. Vilanterol has a molecular weight of 486.4 and a molecular formula of C 24 h 33 Cl 2 NO 5 , CAS: 503068-34-6, Chinese name: Chemical name: (R)-4-[2-[[6-[(2,6-dichlorobenzyl)oxy]-ethoxy]ethyl ]amino]-1-hydroxyethyl]-2-hydroxyethyl]-2-hydroxymethylphenol, the chemical structural formula is as follows: [0003] [0004] The world patent WO2003024439 relates to a method for synthesizing vilanterol, the specific synthe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C59/52C07C51/367
CPCC07C51/367C07C59/52
Inventor 张启龙郑庚修汪崇文许坤李学坤
Owner 安徽德信佳济大新药技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products